Salīdzināt metodes

	EQ-5D	HAQ invaliditātes indekss	SF-36 veselības aptauja
Nozare	Veselības mērīšana	Veselības mērīšana	Veselības mērīšana
Saime	Process / pipeline	Process / pipeline	Process / pipeline
Izcelsmes gads	1990	1980	1992
Autors	EuroQol Group	James Fries and colleagues at Stanford University	John E. Ware Jr. and Cathy D. Sherbourne
Tips	Generic preference-based health utility measure	Functional disability measurement for arthritis and chronic disease	Self-report health status instrument
Pirmavots	Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.	Bruce, B., & Fries, J. F. (1989). The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. Journal of Rheumatology, 16(8), 1055–1064.	Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
Citi nosaukumi	EQ-5D-3L, EQ-5D-5L, EuroQol	HAQ-DI, Health Assessment Questionnaire, Disability Index	SF-36 Questionnaire, Medical Outcomes Study SF-36
Saistītās	5	5	5
Kopsavilkums	The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990. It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide.	The Health Assessment Questionnaire Disability Index (HAQ-DI) is a 20-item self-report measure of functional disability developed by Fries and colleagues at Stanford University in 1980. Originally designed for rheumatoid arthritis, the HAQ-DI has become the gold-standard functional assessment instrument across diverse rheumatic diseases and chronic conditions.	The SF-36 is a generic, self-administered 36-item questionnaire measuring eight dimensions of health status. Developed by Ware and Sherbourne in 1992, it has become the most widely used health survey in clinical trials, outcomes research, and population health monitoring. It assesses perceived health across physical and mental domains relevant to the general adult population.